MAPK ERK1/2 cascade
Selected indexed studies
- Navigating the ERK1/2 MAPK Cascade. (Biomolecules, 2023) [PMID:37892237]
- RAF-MEK-ERK pathway in cancer evolution and treatment. (Semin Cancer Biol, 2022) [PMID:33992782]
- Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. (J Recept Signal Transduct Res, 2015) [PMID:26096166]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Navigating the ERK1/2 MAPK Cascade. (2023) pubmed
- RAF-MEK-ERK pathway in cancer evolution and treatment. (2022) pubmed
- Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. (2015) pubmed
- ERK1/2 in immune signalling. (2022) pubmed
- Negative feedback regulation of the ERK1/2 MAPK pathway. (2016) pubmed
- Targeting the ERK1/2 and p38 MAPK pathways attenuates Golgi tethering factor golgin-97 depletion-induced cancer progression in breast cancer. (2025) pubmed
- Tolperisone hydrochloride improves motor functions in Parkinson's disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade. (2024) pubmed
- Chromatin-tethered MAPKs. (2013) pubmed
- Targeting of MAPK-ERK1/2 signaling by metformin in asthma: an updated mechanistic insight. (2026) pubmed
- CX3CL1 attenuates neurological deficit and neuroinflammation through CX3CR1/p38 MAPK/ERK1/2 signaling pathway in traumatic brain injury. (2026) pubmed